Recruiting NCT05845801
Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Register.
- Who it may be relevant to
- Registry conditions: PDAC - Pancreatic Ductal Adenocarcinoma. Basic parameters: 18 years — 55 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Italy
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The objective of the present registry is the creation of a prospective registry collecting clinico-pathological and genomic data, along with survival outcomes, of individuals diagnosed with PDAC at or before the age of 55 years old. This registry is intended with the aim of using collected data for future clinical trials, both prospective and retrospective.
Interventions
- Other Register
Prospective collection of epidemiological, clinical, and pathological data of patients diagnosed with early-onset pancreatic cancer (EO-PDAC) - namely, individuals who have received a diagnosis of pancreatic cancer before, or at, the age of 55 years old.
Primary outcome measures
- Register of young PDAC patients [Time frame: 30 years]
Eligibility criteria
Inclusion criteria
- Age ≤55 years old at the time of diagnosis of pancreatic cancer
- Age ≥ 18 years
- Written informed consent obtained.
Exclusion criteria
- Any pancreatic neoplasm other than pancreatic cancer (e.g. cholangiocarcinoma, ampullary cancer,duodenal cancer, non-invasive mucinous cystic neoplasm, pancreatic intra-epithelial neoplasia 1 and 2, non-invasive intraductal papillary mucinous neoplasm, serous cystic neoplasm, pseudo papillary solid tumor, neuroendocrine tumor)
- Absence of informed consent.
- Age < 18 years or > 55 years old at the time of diagnosis of pancreatic cancer
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Other
Study locations
Italy · 1 center
- AOUI Verona — Verona
Identifiers
NCT: NCT05845801 · 3968